Results 171 to 180 of about 68,973 (285)
Mapping neurophysiological and molecular profiles of heterogeneity and homogeneity in schizophrenia-bipolar disorder. [PDF]
Li F +10 more
europepmc +1 more source
Evaluating the optimal duration of medication treatment for opioid use disorder
Abstract Background and aims Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how the risk of all‐cause mortality changes with the duration of MOUD, controlling for patient characteristics that ...
Corey J. Hayes +5 more
wiley +1 more source
Acute mania and psychosis potentially triggered by St John's wort. [PDF]
Yoshioka D, Yamanashi T, Iwata M.
europepmc +1 more source
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty +2 more
wiley +1 more source
Drug use among people in prison: A global review of epidemiology, harms and interventions
Abstract Background and aims People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.
Louis Favril, John Strang, Seena Fazel
wiley +1 more source
The eye-mind connection: a systematic review of retinal biomarkers and ocular signatures in major psychiatric disorders. [PDF]
Motamedi R +15 more
europepmc +1 more source
A Case Report of Family Relations in Shared Psychotic Disorder
Janiasman Alexsandro Sinurat +1 more
openaire +1 more source
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley +1 more source
Abstract Growing evidence supports the efficacy of various psychosocial interventions yet provides very little information about the potential harms and burdens of treatment. Lacking such information makes it difficult to make truly informed decisions about treatment options.
Raquel W. Halfond +2 more
wiley +1 more source

